Medpace Holdings ROA 2014-2023 | MEDP
Medpace Holdings ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2023-12-31 | $0.28B | $1.66B | 19.03% |
2023-09-30 | $0.27B | $1.49B | 19.43% |
2023-06-30 | $0.27B | $1.41B | 19.62% |
2023-03-31 | $0.26B | $1.40B | 19.07% |
2022-12-31 | $0.25B | $1.35B | 18.36% |
2022-09-30 | $0.23B | $1.33B | 16.01% |
2022-06-30 | $0.21B | $1.32B | 14.18% |
2022-03-31 | $0.20B | $1.34B | 13.22% |
2021-12-31 | $0.18B | $1.66B | 11.82% |
2021-09-30 | $0.18B | $1.58B | 12.36% |
2021-06-30 | $0.17B | $1.47B | 12.41% |
2021-03-31 | $0.16B | $1.45B | 11.79% |
2020-12-31 | $0.14B | $1.39B | 11.41% |
2020-09-30 | $0.12B | $1.30B | 10.34% |
2020-06-30 | $0.11B | $1.22B | 9.36% |
2020-03-31 | $0.11B | $1.14B | 10.07% |
2019-12-31 | $0.10B | $1.14B | 9.44% |
2019-09-30 | $0.09B | $1.07B | 9.06% |
2019-06-30 | $0.09B | $1.02B | 8.83% |
2019-03-31 | $0.08B | $1.01B | 7.91% |
2018-12-31 | $0.07B | $0.97B | 7.57% |
2018-09-30 | $0.06B | $0.95B | 6.45% |
2018-06-30 | $0.05B | $0.97B | 5.52% |
2018-03-31 | $0.05B | $0.97B | 4.80% |
2017-12-31 | $0.04B | $0.95B | 4.07% |
2017-09-30 | $0.03B | $0.95B | 2.90% |
2017-06-30 | $0.02B | $0.96B | 2.37% |
2017-03-31 | $0.02B | $0.97B | 2.46% |
2016-12-31 | $0.01B | $0.98B | 2.66% |
2016-06-30 | $0.01B | $0.00B | inf% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $11.849B | $1.886B |
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $118.437B | 15.37 |
Cencora (COR) | United States | $47.600B | 19.00 |
ICON (ICLR) | Ireland | $24.090B | 23.76 |
DiDi Global (DIDIY) | China | $22.541B | 0.00 |
Avantor (AVTR) | United States | $16.537B | 22.78 |
CochLear (CHEOY) | $13.442B | 0.00 | |
Viatris (VTRS) | United States | $13.316B | 3.80 |
Revvity (RVTY) | United States | $12.420B | 21.62 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
Charles River Laboratories (CRL) | United States | $11.852B | 21.60 |
Natera (NTRA) | United States | $10.908B | 0.00 |
Solventum (SOLV) | United States | $10.653B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.853B | 51.20 |
Bausch + Lomb (BLCO) | Canada | $5.029B | 19.34 |
Doximity (DOCS) | United States | $4.699B | 34.99 |
Organon (OGN) | United States | $4.568B | 4.42 |
Progyny (PGNY) | United States | $3.148B | 52.82 |
Surgery Partners (SGRY) | United States | $3.098B | 28.79 |
Sotera Health (SHC) | United States | $3.043B | 14.93 |
Life Times (LTH) | United States | $2.713B | 29.98 |
GoodRx Holdings (GDRX) | United States | $2.567B | 130.00 |
Premier (PINC) | United States | $2.473B | 9.05 |
Teladoc Health (TDOC) | United States | $2.225B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.137B | 6.91 |
Agilon Health (AGL) | United States | $2.052B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.758B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.432B | 0.00 | |
Agiliti (AGTI) | United States | $1.365B | 22.29 |
NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
Alignment Healthcare (ALHC) | United States | $0.935B | 0.00 |
Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
Embecta (EMBC) | United States | $0.590B | 3.89 |
Auna S.A (AUNA) | Luxembourg | $0.554B | 0.00 |
InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
Enhabit (EHAB) | United States | $0.510B | 46.18 |
MultiPlan (MPLN) | United States | $0.467B | 0.00 |
CareDx (CDNA) | United States | $0.429B | 0.00 |
Beauty Health (SKIN) | United States | $0.409B | 0.00 |
LifeMD (LFMD) | United States | $0.398B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
DocGo (DCGO) | United States | $0.350B | 56.00 |
Sera Prognostics (SERA) | United States | $0.314B | 0.00 |
ModivCare (MODV) | United States | $0.295B | 3.91 |
Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.240B | 0.00 |
Sharecare (SHCR) | United States | $0.237B | 0.00 |
Biodesix (BDSX) | United States | $0.117B | 0.00 |
So-Young (SY) | China | $0.116B | 39.00 |
Oncology Institute (TOI) | United States | $0.087B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.065B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
NeueHealth (NEUE) | United States | $0.048B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
OpGen (OPGN) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Assure Holdings (IONM) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |